CJC-1295 + DAC 2MG

CJC-1295 DAC is a synthetic secretagogue that stimulates the release of growth hormones. It is an agonist of the growth hormone-releasing hormone (GHRH) and it exerts its effect by binding with GHRH receptors in the anterior pituitary. A Canadian company by the name of ConjuChem Technologies first synthesized this peptide in 2000 in order to overcome the limitation of injectable growth hormones with a half-life of just 7 minutes.

TCJC-1295 DAC is composed of 29 amino acids. It differs from CJC-1295 by having DAC (direct affinity complex) attached to it. DAC is attached to the molecule with the help of lysine linker. This modification prevents the breakdown of CJC-1295 and allows it to bind with plasma albumin, thus prolonging its half-life. Research shows that CJC-1295 DAC has a half-life of 5-8 days while CJC-1295 has a half-life of just 30 minutes [1]. Due to its prolonged duration, it has the potential to be used in a clinical setting. On our website, CJC-1295 DAC for sale is available for research purposes.

Molecular Formula: C171H281N49O47
Molecular Weight: 3775.4 g/mol
CAS Number: 863288-34-0

1. CJC-1295 DAS Research

CJC-1295 stimulate growth hormone release in a pulsatile manner like natural GHRH [2]. Research in mice with GHRH gene ablation found that administration of CJC-1295 resulted in normal body weight and length, suggesting it might be effective in treating growth-related disorders [3]. CJC-1295 has long half and prolonged duration of action. One study found its association with a 2-3 fold increase in growth hormone for 6 days and a 1.5-1.3 fold increase in IGF-1 levels for 9-11 days [1].

2. Current status of CJC-1295 DAC:

There’s not much literature available on the effects of CJC-1295 DAC. But it has the potential to treat growth hormone-related disorders. It’s not approved by FDA, but its usage for youthful appearance has been noticed among females [4]. We don’t support its unwarranted clinical use. At Element SARMS, CJC-1295 DAC purchase is restricted to educational and research purposes. Only buy CJC-1295 DAC if you are a licensed researcher.

1. Teichman, S.L., et al., Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor I Secretion by CJC-1295, a Long-Acting Analog of GH-Releasing Hormone, in Healthy Adults. The Journal of Clinical Endocrinology & Metabolism, 2006. 91(3): p. 799-805.
2. Ionescu, M. and L.A. Frohman, Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab, 2006. 91(12): p. 4792-7.
3. Alba, M., et al., Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse. Am J Physiol Endocrinol Metab, 2006. 291(6): p. E1290-4.
4. Van Hout, M.C. and E. Hearne, Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions. Subst Use Misuse, 2016. 51(1): p. 73-84.